Key facts
- This page summarizes Michael J. Dunn's Form 4 filing for CalciMedica, Inc. (CALC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Sep 2024, 17:00.
Michael J. Dunn - 09 Sep 2024 Form 4 Insider Report for CalciMedica, Inc. (CALC)
- Reporting relationship
- President and COO
- Issuer ticker
- CALC
- Reported as of
- 09 Sep 2024
- Net transaction value
- +$16,348
- SEC form
- 4
- Accepted by SEC
- 11 Sep 2024, 17:00:06 UTC
- Prior SEC filing
- 28 Aug 2024
- Next SEC filing
- 25 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Dunn, Esq., Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael J. Dunn filed Form 4 for CalciMedica, Inc. (CALC) on 11 Sep 2024.
Change
- Previous filing in this sequence was filed on 28 Aug 2024.
- Current net transaction value: +$16,348.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CALC
transaction
Common Stock
Options Exercise
- Transaction value
- $16,348
- Shares
- +11,761
- Change %
- Price
- $1.39
- Shares after
- 11,761
- Date
- 09 Sep 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CALC
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -11,761
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 09 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,761
- Exercise price
- $1.39
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Immediately exercisable.
Footnote F2
Received in exchange for a stock option to acquire 408,402 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer (formerly known as Graybug Vision, Inc.) and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.